Thromb Haemost 1978; 39(01): 039-045
DOI: 10.1055/s-0038-1646652
Original Article
Schattauer GmbH Stuttgart

Studies of Fibrinogen Metabolism in Healthy and Hypertensive Female Subjects with the Use of Autologous I-125-Fibrinogen

Y Takeda
The Department of Medicine, University of Colorado, Medical Center, 4200 East Ninth Avenue, Denver, Colorado 80220, U.S.A.
,
T Takeuchi
The Department of Medicine, University of Colorado, Medical Center, 4200 East Ninth Avenue, Denver, Colorado 80220, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 22 June 1997

Accepted 08 August 1997

Publication Date:
12 July 2018 (online)

Summary

10 healthy female subjects and 15 female patients with essential hypertension were studied with respect to fibrinogen metabolism in a steady state. Autologous I-125-labeled fibrinogen (I-125-fibrinogen) was used as a tracer. Comparison of the results showed that plasma volume, t½ of plasma I-125-fibrinogen and fractional catabolic rate (j3p) of plasma fibrinogen were not appreciably different in both groups of subjects, but plasma fibrinogen concentration, and catabolic flux of (synthesis rate) were significantly higher in hypertensive subjects, whereas extravascular fibrinogen and fractional transcapillary transfer rate (j1) of were significantly decreased in the patients. Further analyses of the data in both groups showed that there were significant correlations between diastolic blood pressure (P) and j1 with a regression equation of j1 = e−0.0285P, between 1 and between and j1 with a regression equation of 1. These results indicate that the observed decrease of j1 triggered the transition from normal to pathological steady state and is responsible for the altered metabolism and distribution of fibrinogen in hypertensive subjects.

 
  • References

  • 1 Atencio AC, Burdick DC, Reeve EB. 1965; An accurate isotope dilution method for measuring plasma fibrinogen. Journal of Laboratory and Clinical Medicine 66: 137
  • 2 Bancroft H. 1957. Introduction to Biostatistics. 1st ed PaulB. Hoeber, Inc.; New York: 162-167
  • 3 Conway J. 1960; The nature of the increased peripheral resistance in hypertension. American Journal of Cardiology 5: 649
  • 4 McFarlane AS. 1958; Efficient tracer-labeling of proteins with iodine. Nature 183: 53
  • 5 Mel’nikov AF. 1963; State of blood coagulation at different stages in arterial hypertension. Federation Proceedings 22: T74
  • 6 Reeve EB, Roberts JE. 1959; The kinetics of the distribution and breakdown of I-131-albumin in the rabbit. Journal of General Physiology 43: 415
  • 7 Snedecor GW. 1957. Statistical Methods. 5th ed The Iowa State College Press; Iowa: 160-193
  • 8 Society of Actuaries. 1959. Build and Blood Pressure Study. Vol. 1 Peter F. Mallon, Inc.; New York: 1732and -36
  • 9 Solomon AK. 1953; The kinetics of biological processes. Special problems connected with the use of tracers. Advances in Biology Medicine and Physics 3: 65
  • 10 Pickering GW. 1968. High Blood Pressure. 2nd ed J. & A. Churchill Ltd.; London: 25-61
  • 11 Pickering GW. 1974. Hypertension. 2nd ed Churchill Livingstone; Edinburgh & London: 11
  • 12 Takeda Y, Reeve EB. 1962; a Distribution and excretion of I-131-iodide in men on pharmacologic doses of iodide. Journal of Laboratory and Clinical Medicine 60: 944
  • 13 Takeda Y, Reeve EB. 1962; b Studies of the metabolism and distribution of albumin with autologous. I-131-albumin in healthy men. Journal of Laboratory and Clinical Medicine 61: 183
  • 14 Takeda Y. 1966; Studies of the metabolism and distribution of fibrinogen in healthy men with autologous I-125-labeled fibrinogen. Journal of Clinical Investigation 45: 103
  • 15 Takeda Y. 1972; Plasminogen-I-125 responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury. Journal of Clinical Investigation 51: 1363
  • 16 Urbanyuk KG. 1963; Prethrombotic tendency in arterial hypertension. Federation Proceedings 22: T76